65 However, as this was an open-label, uncontrolled trial, it is impossible to assess how much of the improvement was due to a placebo effect
Common adverse effects include: Injection site reactions pain, redness, swelling, or bruising at the intramuscular injection site Gastrointestinal disturbances nausea, diarrhoea, or abdominal discomfort Headache and dizziness particularly following initial doses Skin reactions including rash, pruritus, or acne-like eruptions Flushing temporary redness of the skin Chromaturia red-coloured urine (harmless but can cause concern if unexpected) Less common but more serious reactions include: Hypersensitivity reactions ranging from mild urticaria to anaphylaxis (rare but potentially life-threatening) Hypokalaemia particularly during initial treatment when rapid cell production occurs [5] [16] Temporary changes in blood counts during correction of deficiency Interference with laboratory tests primarily with high-dose IV hydroxocobalamin used for cyanide poisoning, not typically with standard 1mg IM replacement doses Cautions and contraindications: Hypersensitivity to cobalt or vitamin B12 Cyanocobalamin should be avoided in Leber's hereditary optic neuropathy [2] [17] Chloramphenicol may reduce the haematological response to B12 therapy Patients receiving B12 injections outside clinical necessity face unnecessary risks without proven benefit
J Clin Endocrinol Metab 85 : 15181524 Acerini CL et al
5-Amino-1MQ $69.99 $84.99Price range: $69.99 through $84.99 Note: Shipped In Freeze Dried Lyophilized Form Requires Bacteriostatic Water for Reconstitution (Sold Here) Vial Size: 3 mL (Can hold up to 3 mL of BAC Water) FREE shipping on orders $250+ 5-Amino-1MQ is a small molecule compound studied for its inhibitory effect on nicotinamide N-methyltransferase (NNMT), a key enzyme in methylation and cellular energy regulation
MOTS-c is widely regarded as an exercise mimetic
This helps with both normal mitochondria degradation as well as mitochondrial dysfunction-related conditions such as heart failure, ischemia-reperfusion injury, neurodegenerative diseases, and metabolic disorders
